Kiora licenses South Korean rights to KIO-301 to Chong Kun DangAug 19PartnershipKiora Pharmaceuticals Inc
Kiora reports Q2 2026 results, advances KIO-301 and KIO-104 trialsAug 7Quarterly updateKIO-104Kiora Pharmaceuticals Inc
Sign inSign in